Dyslipidemia and its treatment in patients with cerebrovascular disease
10.3760/cma.j.issn.1673-4165.2012.04.009
- VernacularTitle:脑血管病患者的血脂异常及其治疗
- Author:
Shanshan DENG
;
Guinan BI
- Publication Type:Journal Article
- Keywords:
Dyslipidemias;
Lipids;
Stroke;
Cerebrovascular Disorders;
Hydroxymethylglutaryl-CoA Reductase Inhibitors;
Risk Factors
- From:
International Journal of Cerebrovascular Diseases
2012;20(4):284-288
- CountryChina
- Language:Chinese
-
Abstract:
Dyslipidemia refers to the elevated cholesterol,triacylglyceride levels and/or the reduced high density lipoprotein level.It is the important risk factor for the occurrence of atherosclerosis,and it is alsoassociated with the onset and outcome of acute cerebrovascular disease.Therefore,the highly efficient and comprehensive lipid lowering therapy has become one of the most important and effective prevention measures for cerebrovascular disease.This article reviews the recent advances in research on dyslipidemia and lipid lowering therapy in patients with cerebrovascular disease.
